Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (351-360 of 940) with videos related to

Pageof 94
Sort By:
Journal of Neuro-Oncology|September 21, 2002
Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II studyWolfgang Wick, Mirjam Hermisson, Rolf D Kortmann, et al.
Neuro-Oncology|November 11, 2020
The molecular evolution of glioblastoma treated by gross total resection aloneDorothee Gramatzki, Jörg Felsberg, Patrick Roth, et al.
International Journal of Cancer|December 15, 2018
Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibitionEmilie Le Rhun, Caroline von Achenbach, Birthe Lohmann, et al.
Glia|November 7, 2003
Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivoBettina Schreiner, Jörg Wischhusen, Meike Mitsdoerffer, et al.
Multiple Sclerosis and Related Disorders|April 29, 2022
Prognosis of walking function in multiple sclerosis supported by gait pattern analysisBjörn Zörner, Pascal Hostettler, Christian Meyer, et al.
International Journal of Oncology|April 30, 2010
Glioma tropism of lentivirally transduced hematopoietic progenitor cellsGhazaleh Tabatabai, Kathy Hasenbach, Caroline Herrmann, et al.
Scientific Reports|October 22, 2015
Computer-assisted quantification of motile and invasive capabilities of cancer cellsKarthiga Santhana Kumar, Max Pillong, Jens Kunze, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 7, 2023
Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated diseaseLaura Skarsta, Tommaso Nicoletti, Katja Frick, et al.
Acta Neuropathologica Communications|March 14, 2023
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibitionManuela Silginer, Eleanna Papa, Emese Szabó, et al.
Journal of Neuro-Oncology|May 1, 2021
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progressionJonathan Weller, Sophie Katzendobler, Philipp Karschnia, et al.
Pageof 94

Showing results (351-360 of 940) with videos related to

Sort By:
Pageof 94
Journal of Neuro-Oncology|September 21, 2002
Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II studyWolfgang Wick, Mirjam Hermisson, Rolf D Kortmann, et al.
Neuro-Oncology|November 11, 2020
The molecular evolution of glioblastoma treated by gross total resection aloneDorothee Gramatzki, Jörg Felsberg, Patrick Roth, et al.
International Journal of Cancer|December 15, 2018
Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibitionEmilie Le Rhun, Caroline von Achenbach, Birthe Lohmann, et al.
Glia|November 7, 2003
Expression of the B7-related molecule ICOSL by human glioma cells in vitro and in vivoBettina Schreiner, Jörg Wischhusen, Meike Mitsdoerffer, et al.
Multiple Sclerosis and Related Disorders|April 29, 2022
Prognosis of walking function in multiple sclerosis supported by gait pattern analysisBjörn Zörner, Pascal Hostettler, Christian Meyer, et al.
International Journal of Oncology|April 30, 2010
Glioma tropism of lentivirally transduced hematopoietic progenitor cellsGhazaleh Tabatabai, Kathy Hasenbach, Caroline Herrmann, et al.
Scientific Reports|October 22, 2015
Computer-assisted quantification of motile and invasive capabilities of cancer cellsKarthiga Santhana Kumar, Max Pillong, Jens Kunze, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 7, 2023
Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated diseaseLaura Skarsta, Tommaso Nicoletti, Katja Frick, et al.
Acta Neuropathologica Communications|March 14, 2023
Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibitionManuela Silginer, Eleanna Papa, Emese Szabó, et al.
Journal of Neuro-Oncology|May 1, 2021
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progressionJonathan Weller, Sophie Katzendobler, Philipp Karschnia, et al.
Pageof 94